Diagnosing Dx
by Elevra Consulting
Why Does Better Diagnostic Science Struggle to Reach Patients?…
About this podcast
How do we transform cutting-edge scientific discoveries into life-saving diagnostics?
On Diagnosing Dx, we explore the scientific innovation driving diagnostics forward, unpack industry challenges, and spotlight success stories. Join us as we speak with leading researchers and innovators at the forefront of Dx.
Learn to:
🔹 Navigate industry challenges
🔹 Understand emerging science
🔹 Strategise for growth
🔹 Gain future-focused insight
Essential listening for everyone involved in bringing new sciences to life in the Dx and Omics industry, Subscribe now!
Episodes
The newest 20 of 64 episodes
- Why Does Better Diagnostic Science Struggle to Reach Patients? Hannah Mamuszka, Founder Alva10 · 44 minIn this episode of Diagnosing Dx, David Filby is joined by Hannah Mamuszka, Founder of Alva10. After more than 20 years in the diagnostics industry, Hannah has seen first-hand…
- Is AI About to Redefine What a Diagnostics Company Does? Sivan Bercovici, CTO & CBO - Karius · 39 minIn this episode of Diagnosing Dx, David Filby is joined by Sivan Bercovici, Chief Technology Officer and Chief Business Officer at Karius. With more than two decades working at…
- Can AI Help Us Treat Cancer Without Overtreating Patients? Oliver Bathe, Qualisure Diagnostics · 33 minIn this episode of Diagnosing Dx, David Filby is joined by Dr Oliver Bathe, Founder and CEO of Qualisure Diagnostics. After more than 25 years as a surgical oncologist, Oliver…
- Could Genomic Testing Be as Accessible as a Smartphone? Ana Cornell, CEO & Founder of Acorn Genetics · 39 minIn this episode of Diagnosing Dx, David Filby is joined by Ana Cornell, Founder and CEO of Acorn Genetics. Ana started Acorn after experiencing first-hand how expensive and…
- Could High Frequency Monitoring Transform Autoimmune Care? Kavya Swaminathan · 43 minIn this episode of Diagnosing Dx, David Filby is joined by Kavya Swaminathan, PhD, Co-Founder and CEO of Kascaid. An immunologist and proteomics scientist by training, Kavya has…
- Could a 10-Minute Test Stop Unnecessary Antibiotic Prescribing? Paul Kase, CCO - Lumos Diagnostics · 37 minIn this episode of Diagnosing Dx, David Filby is joined by Paul Kase, Chief Commercial Officer at Lumos Diagnostics. Paul brings 30 years of healthcare experience, including more…
- Will Payer-Dependent Diagnostics Companies Get Left Behind? Marty Keiser, Founder at IVBH / Mammogen · 35 minIn this episode of Diagnosing Dx, David Filby is joined by Marty Keiser, Founder and CEO of IVBH. After beginning his career in asset management and capital markets, Marty moved…
- What If the Patients Who Need Your Test Are Already Hiding in the EHR? Sagacity Diagnostics · 38 minIn this episode of Diagnosing Dx, David Filby is joined by Raymond Tarr, Founder of Sagacity Diagnostics. Raymond brings more than 25 years of experience across diagnostics, rare…
- Can Strategic Partnerships Save Diagnostics Innovation? Robert Carlson · 43 minIn this episode of Diagnosing Dx, David Filby is joined by Robert Carlson, Founder and President of Life Science Dx Consulting. Robert brings 30 years of experience across…
- Could More Frequent Blood Testing Transform How We Detect Disease? · 40 minIn this episode of Diagnosing Dx, David Filby is joined by Octavian Florescu, CEO of In Diagnostics. An electrical engineer and microchip designer by training, Octavian has…
- Why Are Vector-Borne Infections Still So Difficult to Diagnose? · 36 minIn this episode of Diagnosing Dx, David Filby is joined by Nicole Bell, CEO of Galaxy Diagnostics. Nicole’s route into vector-borne disease diagnostics is deeply personal. After…
- What Can Diagnostics Founders Learn From Two Successful Exits? Andrew Miller · 36 minIn this episode of Diagnosing Dx, David Filby is joined by Andrew Miller, a diagnostics founder, advisor and two-time exited CEO. A scientist by training, Andrew founded and led…
- 98% of Cancer Patients Outside the US Miss Genomic Testing. Can AI Change That? · 39 minIn this episode of Diagnosing Dx, David Filby is joined by Travis Wold, Chief Executive Officer at Imagenomix. Travis brings experience across cancer diagnostics, genomics…
- Could 20-Minute Hormone Testing Transform Patient Care? Nedal Safwat, SVP at Canatu · 46 minIn this episode of Diagnosing Dx, David Filby is joined by Nedal Safwat, Senior Vice President of Medical Diagnostics at Canatu and President of Canatu Inc. With more than 20…
- Could a $127M Seed Round Change Women's Health Forever? - Dean Remy, Co-Founder @ Mativa Dx · 38 minIn this episode of Diagnosing Dx, David Filby is joined by Dean Remy, Co-Founder and Chief Commercial Officer at Mativa Diagnostics. Dean brings 35 years of experience across…
- Red Drop’s Bet on Pain-Free Blood Collection and the Next Wave of Diagnostics · 38 minIn this episode of Diagnosing Dx, David Filby is joined by Thomas Briggs, Chief Growth Officer at RedDrop Dx. Thomas brings more than 25 years of diagnostics and healthcare…
- Why Cancer Patients Still Die From Infections We Can't Diagnose - Karius · 51 minIn this episode of Diagnosing Dx, David Filby is joined by Alec Ford, Chief Executive Officer at Karius. Alec brings decades of leadership experience across therapeutics…
- Can AI Rescue Cancer Drugs That Clinical Trials Say Have Failed? · 36 minIn this episode of Diagnosing Dx, David Filby is joined by Alexander Bagaev, Chief Product Officer at BostonGene. Alexander has spent more than a decade helping build BostonGene…
- What If We Could Test Depression Drugs Before Patients Take Them? Dr Talia Cohen Solal - NeuroKaire · 29 minIn this episode of Diagnosing Dx, David Filby is joined by Talia Cohen Solal, CEO at NeuroKaire. Talia is a neuroscientist by training who spent more than a decade in academia…
- Why AI Multiomics Will Replace Ultrasound in Liver Cancer Screening with Bharat Tewarie · 31 minIn this episode of Diagnosing Dx, David Filby is joined by Bharat Tewarie, MD, MBA, CEO at Helio Genomics. Bharat has led Helio Genomics since July 2025, bringing decades of…








